Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 34 entries
View as:

A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)

Phase: N/A Priority: Normal
NCT ID: NCT02402309 Org: User:
Start: 03/31/15 End: 06/30/16 Due: 06/30/17

A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels

Phase: N/A Priority: Normal
NCT ID: NCT05487404 Org: User:
Start: 11/15/21 End: 05/29/22 Due: 05/29/23

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

Phase: N/A Priority: Normal
NCT ID: NCT04136366 Org: User:
Start: 11/15/19 End: 06/14/22 Due: 06/14/23

A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

Phase: N/A Priority: Normal
NCT ID: NCT05717920 Org: User:
Start: 02/15/23 End: 11/21/23 Due: 11/21/24

The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT05062330 Org: User:
Start: 08/28/21 End: 03/04/22 Due: 03/04/23

The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.

Phase: N/A Priority: Normal
NCT ID: NCT04207736 Org: User:
Start: 12/05/19 End: 02/16/21 Due: 02/16/22

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT03660878 Org: User:
Start: 09/08/18 End: 11/19/19 Due: 11/19/20

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT02578914 Org: User:
Start: 08/31/15 End: 12/31/15 Due: 12/31/16

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

Phase: N/A Priority: Normal
NCT ID: NCT04728711 Org: User:
Start: 01/09/21 End: 01/18/22 Due: 01/18/23

A Study of ADX-102 in Subjects With Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT03012165 Org: User:
Start: 12/31/16 End: 05/31/17 Due: 05/31/18

A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT06389214 Org: User:
Start: 04/09/24 End: 06/11/24 Due: 06/11/25

ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT03494504 Org: User:
Start: 03/30/18 End: 11/05/18 Due: 11/05/19

A Study in Subjects With Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT05392179 Org: User:
Start: 07/14/22 End: 06/23/23 Due: 06/23/24

A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT02406209 Org: User:
Start: 03/31/15 End: 04/30/16 Due: 04/30/17

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT04847544 Org: User:
Start: 03/31/21 End: 10/15/21 Due: 10/15/22

An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber

Phase: N/A Priority: Normal
NCT ID: NCT05102409 Org: User:
Start: 09/09/21 End: 10/25/21 Due: 10/25/22

The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT05234554 Org: User:
Start: 01/21/22 End: 04/22/23 Due: 04/22/24

The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT03879863 Org: User:
Start: 04/16/19 End: 10/04/19 Due: 10/04/20

A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT05424549 Org: User:
Start: 03/09/22 End: 05/09/22 Due: 05/09/23

A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough

Phase: N/A Priority: Normal
NCT ID: NCT05392192 Org: User:
Start: 04/07/22 End: 04/13/23 Due: 04/13/24

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05599815 Org: User:
Start: 01/31/23 End: 05/31/23 Due: 05/31/24

A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03162783 Org: User:
Start: 05/15/17 End: 07/06/17 Due: 07/06/18

A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04908514 Org: User:
Start: 05/07/21 End: 01/21/22 Due: 01/21/23

A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber

Phase: N/A Priority: Normal
NCT ID: NCT03709121 Org: User:
Start: 10/02/18 End: 03/20/19 Due: 03/20/20

A Clinical Trial to Assess Subjects With Dry Eye Disease.

Phase: N/A Priority: Normal
NCT ID: NCT04971031 Org: User:
Start: 06/15/21 End: 09/08/21 Due: 09/08/22